Mereo Biopharma Group Stock Technical Analysis
| MREO Stock | USD 2.78 0.01 0.36% |
As of the 25th of April, Mereo BioPharma secures the Standard Deviation of 3.97, mean deviation of 2.9, and Risk Adjusted Performance of (0.01). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mereo BioPharma Group, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Mereo BioPharma, which can be compared to its peers in the industry. Please verify Mereo BioPharma Group market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Mereo BioPharma Group is priced some-what accurately, providing market reflects its recent price of 2.78 per share. Please also check out Mereo BioPharma jensen alpha, which is currently at (0.27) to check the company can sustain itself at a future point.
Mereo BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mereo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MereoMereo |
Mereo BioPharma Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.25 | Strong Buy | 4 | Odds |
Most Mereo analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mereo stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mereo BioPharma Group, talking to its executives and customers, or listening to Mereo conference calls.
Mereo BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Mereo BioPharma Group Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Mereo BioPharma Group volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Mereo BioPharma Group Trend Analysis
Use this graph to draw trend lines for Mereo BioPharma Group. You can use it to identify possible trend reversals for Mereo BioPharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Mereo BioPharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Mereo BioPharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Mereo BioPharma Group applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Mereo BioPharma Group market price will keep on failing further. It has 122 observation points and a regression sum of squares at 19.2, which is the sum of squared deviations for the predicted Mereo BioPharma price change compared to its average price change.About Mereo BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mereo BioPharma Group on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mereo BioPharma Group based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mereo BioPharma Group price pattern first instead of the macroeconomic environment surrounding Mereo BioPharma Group. By analyzing Mereo BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mereo BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mereo BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Mereo BioPharma April 25, 2024 Technical Indicators
Most technical analysis of Mereo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mereo from various momentum indicators to cycle indicators. When you analyze Mereo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 2.9 | |||
| Coefficient Of Variation | (3,374) | |||
| Standard Deviation | 3.97 | |||
| Variance | 15.74 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 21.23 | |||
| Value At Risk | (6.07) | |||
| Potential Upside | 7.69 | |||
| Skewness | 0.7388 | |||
| Kurtosis | 1.21 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mereo BioPharma Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Mereo BioPharma Group information on this page should be used as a complementary analysis to other Mereo BioPharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Mereo Stock analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Mereo BioPharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mereo BioPharma. If investors know Mereo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mereo BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.20) | Revenue Per Share 0.076 | Return On Assets (0.24) | Return On Equity (0.58) |
The market value of Mereo BioPharma Group is measured differently than its book value, which is the value of Mereo that is recorded on the company's balance sheet. Investors also form their own opinion of Mereo BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Mereo BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mereo BioPharma's market value can be influenced by many factors that don't directly affect Mereo BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mereo BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mereo BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mereo BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.